• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞活化综合征:肝活检的特征性表现,阐明了活化的、产生干扰素-γ的淋巴细胞以及产生白细胞介素-6和肿瘤坏死因子-α的巨噬细胞的关键作用。

Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages.

作者信息

Billiau An D, Roskams Tania, Van Damme-Lombaerts Rita, Matthys Patrick, Wouters Carine

机构信息

Pediatric Rheumatology, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium.

出版信息

Blood. 2005 Feb 15;105(4):1648-51. doi: 10.1182/blood-2004-08-2997. Epub 2004 Oct 5.

DOI:10.1182/blood-2004-08-2997
PMID:15466922
Abstract

Macrophage activation syndrome (MAS) is a rare and potentially fatal disorder, thought to result from uncontrolled activation and proliferation of T cells and excessive activation of macrophages. The term MAS designates a clinicopathologic entity that occurs in different hemophagocytic syndromes (HSs). Primary hemophagocytic lymphohistiocytosis (HLH) is recognized to have an immunogenetic basis, but in the secondary HS (also referred to as secondary HLH), the cause is unknown. The pathogenesis of the accelerated disease phase typical of MAS remains incompletely understood. This report describes the immunohistochemical findings on liver tissues from 5 children, each of whom presented with MAS in the context of a different type of HS. The data provide direct evidence for the involvement of activated CD8(+) lymphocytes through the production of interferon-gamma and of macrophages through hemophagocytosis and production of interleukin 6 and tumor necrosis factor-alpha, and underscore the view that MAS in different HSs share a common effector pathway.

摘要

巨噬细胞活化综合征(MAS)是一种罕见且可能致命的疾病,被认为是由T细胞的失控激活和增殖以及巨噬细胞的过度激活所致。术语MAS指的是一种发生于不同噬血细胞综合征(HSs)的临床病理实体。原发性噬血细胞性淋巴组织细胞增生症(HLH)被认为有免疫遗传学基础,但在继发性HS(也称为继发性HLH)中,病因尚不清楚。MAS典型的疾病加速期的发病机制仍未完全明了。本报告描述了5名儿童肝脏组织的免疫组化结果,每名儿童均在不同类型的HS背景下出现MAS。这些数据为活化的CD8(+)淋巴细胞通过产生干扰素-γ参与其中以及巨噬细胞通过噬血细胞作用和产生白细胞介素6和肿瘤坏死因子-α参与其中提供了直接证据,并强调了不同HSs中的MAS共享一条共同效应途径的观点。

相似文献

1
Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages.巨噬细胞活化综合征:肝活检的特征性表现,阐明了活化的、产生干扰素-γ的淋巴细胞以及产生白细胞介素-6和肿瘤坏死因子-α的巨噬细胞的关键作用。
Blood. 2005 Feb 15;105(4):1648-51. doi: 10.1182/blood-2004-08-2997. Epub 2004 Oct 5.
2
Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.在噬血细胞综合征发病机制中,爱泼斯坦-巴尔病毒对肿瘤坏死因子-α基因的上调作用以及该病毒感染的T细胞中巨噬细胞的激活。
J Clin Invest. 1997 Oct 15;100(8):1969-79. doi: 10.1172/JCI119728.
3
Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults.
Br J Haematol. 1994 Jun;87(2):243-50. doi: 10.1111/j.1365-2141.1994.tb04905.x.
4
Macrophage activation and hemophagocytic syndrome in langerhans cell histiocytosis: report of 30 cases.
Pediatr Dev Pathol. 2002 Mar-Apr;5(2):130-40. doi: 10.1007/s10024001-0159-2.
5
Hemophagoctic lymphohistiocytosis--recent concept.噬血细胞性淋巴组织细胞增生症——最新概念
J Assoc Physicians India. 2008 Jun;56:453-7.
6
Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome.中和 IFN-γ 可逆转巨噬细胞活化综合征小鼠模型的临床和实验室特征。
J Allergy Clin Immunol. 2018 Apr;141(4):1439-1449. doi: 10.1016/j.jaci.2017.07.021. Epub 2017 Aug 12.
7
Host defensive, immunological, and microbiological observations of an early-onset periodontitis patient with virus-associated hemophagocytic syndrome.一名患有病毒相关性噬血细胞综合征的早发性牙周炎患者的宿主防御、免疫学及微生物学观察
J Periodontol. 1997 Dec;68(12):1223-30. doi: 10.1902/jop.1997.68.12.1223.
8
[CME: Acquired Hemophagocytic Lymphohistiocytosis].[继续医学教育:获得性噬血细胞性淋巴组织细胞增生症]
Praxis (Bern 1994). 2018 Aug;107(16):873-881. doi: 10.1024/1661-8157/a003040.
9
Human B cells and macrophages cooperate in T-cell-independent type 2 response.人类B细胞和巨噬细胞在2型非T细胞依赖性免疫反应中协同作用。
Scand J Immunol. 2008 Mar;67(3):209-17. doi: 10.1111/j.1365-3083.2007.02057.x. Epub 2008 Jan 10.
10
Familial hemophagocytic lymphohistiocytosis macrophages showing immunohistochemical properties of activated macrophages and T-accessory cells.
Pediatr Hematol Oncol. 1989;6(3):237-46. doi: 10.3109/08880018909034293.

引用本文的文献

1
Tislelizumab-induced hemophagocytic lymphohistiocytosis in a patient with microsatellite instability-high colon cancer and coexisting systemic lupus erythematosus: a case report and literature review.替雷利珠单抗诱导的噬血细胞性淋巴组织细胞增生症在一名微卫星高度不稳定的结肠癌合并系统性红斑狼疮患者中的病例报告及文献复习
Front Oncol. 2025 Aug 6;15:1585133. doi: 10.3389/fonc.2025.1585133. eCollection 2025.
2
A Phase I Trial of Evorpacept, Lenalidomide and Rituximab for Patients with B-cell Non-Hodgkin Lymphoma.依沃西普、来那度胺和利妥昔单抗用于B细胞非霍奇金淋巴瘤患者的I期试验
Clin Cancer Res. 2025 Jul 29. doi: 10.1158/1078-0432.CCR-25-1826.
3
Update in Hyperferritinemic Syndromes: Recognition and Management - A Scoping Review.
高铁蛋白血症综合征的最新进展:识别与管理——一项范围综述
Brown J Hosp Med. 2022 Aug 19;1(3):37667. doi: 10.56305/001c.37667. eCollection 2022.
4
Salvage treatment of AOSD-associated macrophage activation syndrome with bariticinib following conventional immunosuppressive therapy.常规免疫抑制治疗后用巴瑞替尼挽救治疗成人Still病相关巨噬细胞活化综合征。
Clin Rheumatol. 2025 Apr;44(4):1705-1712. doi: 10.1007/s10067-025-07352-9. Epub 2025 Feb 13.
5
Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms.噬血细胞性淋巴组织细胞增生症:当前的治疗进展、新兴的靶向治疗和潜在机制。
J Hematol Oncol. 2024 Nov 7;17(1):106. doi: 10.1186/s13045-024-01621-x.
6
Anti-Interferon-γ Therapy for Cytokine Storm Syndromes.抗干扰素-γ治疗细胞因子风暴综合征。
Adv Exp Med Biol. 2024;1448:573-582. doi: 10.1007/978-3-031-59815-9_38.
7
IL-6 Blockade in Cytokine Storm Syndromes.白细胞介素-6 阻断在细胞因子风暴综合征中的应用。
Adv Exp Med Biol. 2024;1448:565-572. doi: 10.1007/978-3-031-59815-9_37.
8
Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis.细胞因子风暴综合征与全身型幼年特发性关节炎相关。
Adv Exp Med Biol. 2024;1448:323-353. doi: 10.1007/978-3-031-59815-9_23.
9
Clinical Features of Cytokine Storm Syndrome.细胞因子风暴综合征的临床特征。
Adv Exp Med Biol. 2024;1448:33-42. doi: 10.1007/978-3-031-59815-9_4.
10
Heterogeneity of macrophage activation syndrome and treatment progression.巨噬细胞活化综合征的异质性和治疗进展。
Front Immunol. 2024 Apr 26;15:1389710. doi: 10.3389/fimmu.2024.1389710. eCollection 2024.